Biological effects of the administration of an equimolar streptokinase-plasminogen complex in man.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D001161:Arteriosclerosis / Q000097:blood*; D001777:Blood Coagulation / Q000187:drug effects; D004338:Drug Combinations; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008970:Molecular Weight; D010958:Plasminogen / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology*; D013300:Streptokinase / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology*; D013924:Thrombophlebitis / Q000097:blood*
D000906:Antibodies; D004338:Drug Combinations; D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D010958:Plasminogen; D013300:Streptokinase